What is Genuity Science?
Headquartered in Ireland, Genuity Science provides a comprehensive suite of services for the life sciences industry. Their offerings span from sample processing, biobanking, and nucleic acid extraction to advanced techniques such as genotyping, next-generation sequencing, and methylation profiling, culminating in detailed data delivery. The company operates at the intersection of biotechnology and data analytics, supporting research and development initiatives.
How much funding has Genuity Science raised?
Genuity Science has raised a total of $620M across 4 funding rounds:
Series A
$15M
Series B
$165M
Unspecified
$240M
Series C
$200M
Series A (2013): $15M with participation from Polaris Partners and ARCH Venture Partners
Series B (2017): $165M led by 3W Partners, Yunfeng Capital, Amgen Business Development, Sequoia China, and Temasek
Unspecified (2017): $240M supported by Steamboat Ventures, Yunfeng Capital, 3W Partners, and Temasek
Series C (2018): $200M featuring Temasek, Ireland Strategic Investment Fund, Yunfeng Capital, and Steamboat Ventures
Key Investors in Genuity Science
Temasek
Temasek is a Singaporean state-owned investment company known for its long-term investment approach across various sectors, including life sciences and technology.
Yunfeng Capital
Yunfeng Capital is a Chinese private equity firm that typically invests in technology, healthcare, and consumer sectors, often focusing on growth-stage companies.
Steamboat Ventures
Steamboat Ventures is the venture capital arm of The Walt Disney Company, historically investing in technology and media companies, but also showing interest in broader innovation.
What's next for Genuity Science?
With a significant infusion of capital, Genuity Science is poised for accelerated growth and strategic development. The major enterprise-level funding suggests a focus on scaling operations, expanding service capabilities, and potentially entering new markets. The recent strategic investment indicates strong backing from key players, likely aimed at leveraging Genuity Science's expertise in genomic services and biobanking to advance their own research or commercial objectives. Future endeavors may include enhancing their technological infrastructure, forging new partnerships, and broadening their client base within the pharmaceutical, biotech, and academic research communities.
See full Genuity Science company page
